Cellulite treatment advertising: what clinics can claim

Cellulite ads promise a lot in a few words: “smooth thighs in one session,” “permanent cellulite removal,” “melts cellulite,” “FDA-approved cellulite treatment.” Each of those phrases is a claim about what a device, injectable or cream does to the body. Federal rules decide how a product can be described, and the FTC Act asks whether you can prove the claim before you publish it.

This guide is for med spas, dermatology and plastic surgery practices and body contouring clinics that offer cellulite treatments. It covers device wording, the injectable approved for cellulite, creams you sell, “permanent” and speed claims, before-and-after photos and package prices. We do not name any product, device, brand or company. For fat reduction devices, see our guide to body contouring clinic marketing, and for fat-dissolving injections, our guide to fat-dissolving injection marketing. Vibration platforms are covered in our guide to whole body vibration marketing claims.

This is general information, not legal or medical advice. Sources cited were checked on November 2, 2026: 21 CFR 878.4790 and 807.97, 21 CFR 202.1, and 16 CFR 233.1 and 255.2 in the eCFR version as of October 29, 2026; FDA product classification records for product codes NUV and PBX; the FDA prescribing information for BLA 761146 (approved July 6, 2020) in Drugs@FDA; FDA’s page “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)” (content current as of September 11, 2024); 15 USC 45 and 52 in the Cornell LII text of the U.S. Code; and the FTC Health Products Compliance Guidance (December 2022). We did not read any state medical board rule. Who may perform cellulite procedures and injections, and who must supervise them, depends on your state. Check with your board and counsel before you advertise.

The short version

Device clearances describe the appearance of cellulite. FDA’s device records for cellulite massagers use words such as “temporarily” and “appearance.” Your ad should not promise more than the cleared use.
“FDA-cleared” is not “FDA-approved.” Under 21 CFR 807.97, implying official approval because a device was cleared through premarket notification is misbranding.
One injectable was approved for one area. FDA approved a collagenase injectable in 2020 for moderate to severe cellulite in the buttocks of adult women. Other areas and other patients are outside that indication.
A cream that “reduces cellulite” is a drug claim. FDA names “reduce cellulite” as an example of a claim that makes a product a drug, even if it is sold as a cosmetic.
“Permanent” needs long-term evidence. Under the FTC Act, a claim about how long results last needs competent and reliable scientific evidence for that time frame.
Photos and reviews are your claims. A featured “my cellulite is gone” review counts as a claim you make (16 CFR 255.2).

Why cellulite ads get attention

Cellulite is a cosmetic concern for most people who ask about it, and treatment is almost always paid out of pocket. That combination makes the market crowded: devices, injections, creams, wraps, massage and wellness services all compete for the same search. The person searching often has tried products that did not work and is comparing clinics on price and promised results.

That is the setting where “guaranteed” and “permanent” wording is tempting. It is also where a regulator, a competitor or an unhappy patient will hold you to every word. Write for the reader who is deciding whether to book a consultation, and make the consultation the next step, not the result.

Device claims: read the clearance first

Most in-office cellulite treatments use a device. FDA groups devices by product code, and each code has a definition. Two codes in FDA’s product classification database are written around cellulite:

NUV, massager, vacuum, light induced heating. The record says the device is intended to temporarily alter the appearance of cellulite. Class II.
PBX, massager, vacuum, radio frequency induced heat. The record describes heat for minor relief of minor aches and pains and mechanical massage for a temporary reduction in the appearance of cellulite. Class II.

FDA also created a device type at 21 CFR 878.4790: a powered surgical instrument for improvement in the appearance of cellulite. The regulation describes a prescription device that cuts tissue under the skin, beneath the cellulite depressions or dimples, in a controlled way. It is Class II with special controls.

What this means for your ads:

Ask for the 510(k) or De Novo number and the indication. Read the record in FDA’s databases yourself, then repeat what it says. A sales sheet is not the clearance.
Keep “temporary” when the clearance says temporary. “Temporary reduction in the appearance of cellulite” and “permanent cellulite removal” are different claims. Dropping the word changes the meaning.
Say “appearance” when the indication says appearance. “Improves the appearance of cellulite” matches the records above. “Eliminates cellulite” or “destroys fat cells” does not.
Do not borrow claims from another device. A massager cleared for the temporary appearance of cellulite is not a fat reduction device, and a fat reduction device is not cleared for cellulite unless its own record says so.
Use “FDA-cleared” correctly. 21 CFR 807.97 says premarket notification does not denote official approval, and that a representation creating that impression is misbranding. Write “FDA-cleared for the temporary improvement in the appearance of cellulite” or similar, never “FDA-approved.”

Our guide to medical device marketing claims covers clearance, De Novo and approval wording across specialties.

The injectable approved for cellulite

In Drugs@FDA, BLA 761146 was approved on July 6, 2020. Its prescribing information says it is a combination of bacterial collagenases indicated for the treatment of moderate to severe cellulite in the buttocks of adult women. The warnings section lists hypersensitivity reactions, injection site bruising and a warning against substituting other collagenase products.

If you offer or used to offer this treatment, check that the product is still marketed and available to you before you advertise it. Then keep the ad inside the label:

Area. The indication covers the buttocks. An ad for “injectable cellulite treatment for thighs” goes beyond it.
Patients. The indication names adult women. Do not suggest it is approved for men or teens.
Severity. The indication says moderate to severe cellulite. Say a clinician decides who is a candidate.
Risks. Bruising is a labeled warning. A benefit-only ad leaves out information a patient would want, and under the FTC Act an omission can make an ad misleading.
Other collagenase products. The label warns against substitution. Do not describe a different collagenase product, or a compounded injection, as the approved cellulite treatment.

FDA’s prescription drug ad rules at 21 CFR 202.1 apply to ads issued by a drug’s manufacturer, packer or distributor. Your practice’s own ads are judged mainly under the FTC Act, which still expects truthful, balanced claims. Our guide to prescription treatment advertising explains the split.

Creams, wraps and products you sell

Many clinics sell take-home creams, serums or wraps alongside in-office treatments. FDA’s page on cosmetics and drugs says the intended use decides how a product is regulated, and lists “reduce cellulite” among the claims that make a product a drug, even when it is marketed as a cosmetic. A drug must meet drug rules, which a cosmetic does not.

Product pages and shelf cards that say a cream “reduces,” “breaks down” or “melts” cellulite are drug claims.
Cosmetic wording describes how the skin looks or feels, such as “moisturizes” or “leaves skin feeling smooth,” and still needs to be true.
Staff scripts count. A front-desk line that the cream “gets rid of cellulite” is a claim, just like the label.
Body wraps sold with “inch loss,” “detox” or “melts cellulite” wording carry weight loss and health claims that need evidence.

Wellness services sometimes add cellulite to a list of benefits, as with cupping or vibration. Our guide to cupping therapy marketing claims shows how to strip those lists back to what you can support.

Result claims under the FTC Act

Under the FTC Act, an ad is deceptive if its net impression misleads, and health claims need competent and reliable scientific evidence (15 USC 45 and 52; FTC Health Products Compliance Guidance). Cellulite claims to watch:

Permanence. “Permanent,” “gone for good” and “long-lasting” need evidence covering that period for the treatment you name. If your evidence covers months, say months.
Speed and session counts. “Visible results after one session” needs evidence for one session, for that device or product and protocol.
Percentages. “Reduces cellulite by X percent” is a measured claim. Cite the study it comes from only if the study supports it for your device, protocol and patients.
Comparisons. “Better than surgery” or “the only treatment that works” needs head-to-head evidence.
Guarantees. “Smooth skin guaranteed” promises a result for everyone. If you offer a refund policy, state its terms and do not word it as a promise of results.

Wording that is easier to support:

“We offer FDA-cleared treatments for the temporary improvement in the appearance of cellulite. A consultation helps decide whether one is right for you.”
“Your plan may involve several sessions. Results vary and may not last without maintenance.”
“Possible side effects include bruising, tenderness and swelling. We review risks with you before treatment.”

Check the side effects you list against the device or drug labeling for what you use.

Before-and-after photos and reviews

Cellulite photos are easy to make misleading without retouching. Standing versus relaxed muscles, lighting from above versus from the front, a tan or a different camera distance can change how dimpled skin looks. Keep the before and after photos the same in pose, light, angle, distance and camera settings, and do not retouch.

Typical results. Under 16 CFR 255.2, an ad that features a patient’s results conveys that others can expect them. If the result shown is better than typical, say clearly what patients can generally expect.
Timing. Label how long after the last session the after photo was taken, especially for treatments cleared for a temporary effect.
Consent. Get written authorization from the patient before you post any image of them.
Reviews. Featuring a review that says “my cellulite is completely gone” makes it your claim. Ask patients to review the visit and the care instead.

Our guide to testimonials and before-and-after photos covers consent, retouching and typical-results wording in detail.

Package prices and sales

Cellulite treatments are often sold in session packages, which makes price wording important:

Was and now prices. Under 16 CFR 233.1, a former price should be one you actually offered in good faith for a reasonably substantial period. A “regular price” you never charged makes the discount misleading.
What is included. Say how many sessions, which areas and whether follow-up or maintenance sessions cost extra.
Per-session prices. If an ad shows a single-session price but treatment usually needs several, say so near the price.

See our guide to was and now price claims for more examples. If you want help building pages and campaigns that bring in consultations without risky wording, see our medical lead generation service.

Cellulite ad checklist

Each device ad repeats the indication from its own FDA record, including “temporary” and “appearance” where they appear.
“FDA-cleared” is used for cleared devices; “FDA-approved” only for an approved drug, and only for its labeled use.
Injectable ads stay within the labeled area, patients and severity, and mention bruising and other labeled risks.
Creams and wraps you sell avoid “reduces cellulite” and other drug claims unless the product is a drug.
No “permanent,” percentage, speed or guarantee claims without evidence for your treatment and protocol.
Before-and-after photos consented, matched, unretouched, dated and typical, or with a typical-results statement.
Former prices real and documented; packages say sessions, areas and what costs extra.

Can we say our cellulite treatment is permanent?

Only if you have competent and reliable scientific evidence that the results last that long for the treatment and protocol you use. Several FDA device records for cellulite massagers describe a temporary effect, so “permanent” would go beyond them.

Can we call our cellulite device FDA-approved?

Not if it was cleared through premarket notification. 21 CFR 807.97 says clearance does not denote official approval and that implying approval is misbranding. Say it is FDA-cleared, and only for the use its record names.

Is there an FDA-approved injectable for cellulite?

FDA approved BLA 761146, a collagenase injectable, on July 6, 2020 for moderate to severe cellulite in the buttocks of adult women. Check that it is still available to you before advertising it, and keep ads within that indication.

Can we sell a cream that reduces cellulite?

FDA says a claim that a product will reduce cellulite makes it a drug, even if it is marketed as a cosmetic. A cosmetic can describe how skin looks or feels, but not that it reduces cellulite.

Can we show cellulite before-and-after photos?

Yes, with written patient authorization, matched pose, light and angle, no retouching and a note on timing. If the result is better than typical, say what patients can generally expect (16 CFR 255.2).

Can we advertise a cellulite package discount?

Yes, if the regular price is one you actually charged in good faith for a reasonably substantial period (16 CFR 233.1) and the ad says how many sessions and areas the package includes.

Sources

More in Cash-pay, aesthetic and wellness care

Cellulite treatment marketing: device, injectable and cream claims